IART Q4 2021 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$406M+4.3% YoY

Gross Profit

$249M61.5% margin

Operating Income

$58M14.4% margin

Net Income

$45M11.2% margin

EPS (Diluted)

$0.53

QoQ Revenue Growth

+4.8%

Cash Flow

Operating Cash Flow

$69M

Free Cash Flow

$42M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$3.8B

Total Liabilities

$2.1B

Stockholders' Equity

$1.7B

Cash & Equivalents

$513M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$406M	$389M	+4.3%
Gross Profit	$249M	$242M	+3.2%
Operating Income	$58M	$53M	+10.6%
Net Income	$45M	$93M	-51.1%

Revenue Segments

Codman Specialty Surgical

$271M67%

Tissue Technologies

$135M33%

Geographic Segments

UNITED STATES

$288M71%

Europe

$51M12%

Asia Pacific

$45M11%

Rest Of World

$22M5%